Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

Src

Src (proto-oncogene tyrosine-protein kinase) is a non-receptor protein tyrosine kinase family including 9 members and promotes survival, angiogenesis, proliferation and invasion pathways.

Items 1-10 of 24

Page
per page
  1. Dasatinib (BMS-354825)
    A3017 Dasatinib (BMS-354825)
     4 Citation
    Summary: Src and BCR-Abl inhibitor
      ≥24.4 mg/mL
  2. Dasatinib hydrochloride
    A3351 Dasatinib hydrochloride
    Summary: Multi-BCR/Abl and Src kinase inhibitor, oral active
      insoluble in EtOH; insoluble in H2O; ≥8.41 mg/mL
  3. KX2-391 dihydrochloride
    A3535 KX2-391 dihydrochloride
    Target: Src
    Summary: Src kinase inhibitor
      ≥25.2 mg/mL
  4. XL228
    A3939 XL228
    Summary: IGF1R/AURORA /FGFR1-3/ABL/SRC family kinases inhibitor
      ≥21.9 mg/mL
  5. ER 27319 maleate
    B5308 ER 27319 maleate
    Summary: Selective inhibitor of Syk kinase
      <29.71 mg/mL
  6. MLR 1023
    B5648 MLR 1023
    Target: Lyn kinase
    Summary: allosteric activator of Lyn kinase
  7. KB SRC 4
    B5673 KB SRC 4
    Target: Src
    Summary: c-Src inhibitor
      <11.1 mg/mL
  8. WH-4-023
    B8003 WH-4-023
    Summary: Lck/Src inhibitor,potent and selective
      ≥56.9 mg/mL
  9. SU6656
    B5839 SU6656
    Target: Src|Lyn|YES|Fyn
    Summary: Src tyrosine kinases inhibitor
      insoluble in H2O; insoluble in EtOH; ≥18.55 mg/mL
  10. Saracatinib (AZD0530)
    A2133 Saracatinib (AZD0530)
     3 Citation
    Target: Src
    Summary: Src/Abl inhibitor,potent and selective
      ≥27.1 mg/mL

Items 1-10 of 24

Page
per page